The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...
Urinary and bowel disorders, manifesting as symptoms like frequent urination or difficulty in bowel movements, can greatly impact one’s quality of life, even though they are not outwardly visible.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--StimGuard, a privately-held, pre-commercial stage medical device company, today announced the initiation and the first patient enrollment in a clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback